Increased Eosinophilic Cationic Protein in Nasal Fluid in Hospitalized Wheezy Infants with RSV Infection  by Okamoto, Naoko et al.
Allergology International Vol 60, No4, 2011 www.jsaweb.jp 467
Increased Eosinophilic Cationic
Protein in Nasal Fluid in
Hospitalized Wheezy Infants
with RSV Infection
Naoko Okamoto1, Masanori Ikeda1, Masato Okuda1, Tomoko Sakamoto1, Mizue Takasugi1,
Nobumasa Takahashi1, Toru Araki1, Tsuneo Morishima2 and Kozo Yasui2,3
ABSTRACT
Background: Respiratory syncytial virus (RSV) is a major respiratory pathogen which causes bronchiolitis
with dyspnea and wheezing in children less than 2 years old. RSV bronchiolitis in infancy severe enough to
cause hospitalization might be a risk factor for allergic sensitization and bronchial asthma in future. However,
the pathophysiology behind this development has not been clearly characterized. To evaluate the existence of
airway inflammation and characteristic of RSV bronchiolitis, we analyzed and compared the concentrations of
eosinophilic cationic protein (ECP) in nasal fluid and plasma.
Methods: From 69 infants (aged <2 years) hospitalized for possible lower respiratory tract infections including
RSV infection, we collected nasal fluid and plasma and determined the ECP concentrations.
Results: ECP concentrations in nasal fluid were significantly higher in patients with wheezing andor bronchial
rales than in patients without them (1733 ± 660 ngmL vs 680 ± 450 ngmL, p = 0.018), and those of the respi-
ratory syncitial virus-infected group were significantly higher than those of the uninfected group (p = 0.04).
Meanwhile, there was no significant difference in plasma ECP levels between patients with wheezing and pa-
tients without wheezing, and no significant difference between RSV-infected and other pathogen-infected pa-
tients. There were significant correlations between nasal fluid ECP concentrations and both neutrophil and
eosinophil counts in the peripheral blood.
Conclusions: Nasal fluid ECP concentrations are increased in infants with lower respiratory infections includ-
ing RSV infection accompanied with wheezing. ECP probably originates from neutrophils as well as eosinophils
migrated into airways. The monitoring of ECP concentration in nasal fluid may be useful for evaluating leuko-
cyte (including eosinophils and neutrophils)-mediated airway inflammation during infancy and its severity.
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INTRODUCTION
Persistent inflammation of the airway is thought to be
an essential feature of bronchial asthma. It is gener-
ally argued that young infants with lower respiratory
tract infection [in particular, respiratory syncytial vi-
rus (RSV) infection] may develop recurrent wheezy
bronchitis leading to bronchial asthma. Airway in-
flammation in RSV bronchiolitis is a multicellular
process in which epithelial cells, macrophages, cyto-
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Table　1　Characteristics of the study group
Male : female 44 : 25
With RSV infection : without RSV infection 41 : 28
With wheezing : without wheezing 45 : 24
With predisposition : without predisposition 46 : 23
“With RSV infection” refers to patients whose nasopharyngeal
mucus tested positive for infection using a rapid RSV diagnosis kit.
“With wheezing” refers to the presence of wheezing or bronchial
rales detected during auscultation.
“With predisposition” satisfi es one of the following conditions:
1. An infant with a family history of allergic diseases
2. An infant with any allergic disease other than respiratory dis-
ease
3. Total serum IgE is elevated (>200 U/mL)
toxic T cells and eosinophils are known to be in-
volved.1-4 Additionally, there is increasing direct evi-
dence that neutrophil-mediated inflammation is in-
volved in the pathogenesis of tissue destruction and
the augmentation of bronchial reactivity in RSV bron-
chiolitis.5-7
So far, few studies have characterized the nature of
airway inflammation in infants with RSV infection be-
cause bronchoscopic BAL fluid studies can be too in-
vasive for children. ECP (eosinophil cationic protein)
is an inflammatory protein which is thought to be pro-
duced by eosinophils. A number of studies have sup-
ported that ECP in induced sputum or nasopharyn-
geal secretion can be a useful marker in symptomatic
children with asthma and in the evaluation of eosino-
philic inflammation.8,9 Meanwhile, it has also been re-
ported that ECP originates from neutrophils as well
as eosinophils, because neutrophils contain mRNA
transcripts for ECP and eosinophil-derived neuro-
toxin.10,11 In this study, we analyzed ECP concentra-
tions in the nasal fluid and blood plasma of infants
with lower respiratory tract infection andor wheezy
breathing including RSV bronchiolitis, and attempted
to assess the relation between inflammation of respi-
ratory tract and peripheral blood neutrophil and
eosinophil counts.
METHODS
During the periods from September, 2005 to March,
2006 and September, 2006 to March, 2007, our hospi-
tals admitted 69 infants (Table 1) aged less than 24
months with lower respiratory tract infections. Their
lower respiratory tract infections were defined as low-
ered lung function (low SpO2) and X-ray examina-
tions. The diagnosis of RSV infection was made with
the ABOTT Testpack RSV (Abott, Tokyo, Japan) and
forty-one patients were positive for RSV.
ECP concentrations in plasma were measured at
the time of hospital admission. ECP in the nasal fluid
was also measured in some of the patients. For the
collection of nasal fluid (50 μl), a catheter positioned
at the tip of a syringe was inserted into the nasal cav-
ity to aspirate nasal fluid. The diluted fluid was used
for the determination of the ECP concentration. Each
specimen was mixed well with 5 mL of sterile physi-
ologic saline and centrifuged at 1500 g for 10 min, and
the supernatants were kept at -20℃ until analysis. Na-
sal fluid and blood plasma ECP concentrations were
quantitatively analyzed by a commercially available
monoclonal antibody-based fluorometric immunoas-
say (Pharmacia, Uppsala, Sweden). The lower detec-
tion limit was <0.5 ngmL. There were no infants in
whom corticosteroid inhalation therapy or systemic
corticosteroid therapy were used during hospitaliza-
tion. The study protocol was approved by the ethics
committee of National Fukuyama Medical Center and
Okayama University Hospital, and informed consent
was obtained from all patients and control subjects af-
ter the purpose of the study had been explained.
All data are presented as means ± SD. Compari-
sons of conditions were performed with paired t-tests.
A p value of <0.05 was considered significant in all
cases. Simple regression analyses were performed
with ECP concentrations in several studies.
RESULTS
ECP LEVELS IN PLASMA AND NASAL FLUID IN
RELATION TO THE PRESENCE OF WHEEZING
Plasma ECP levels were measured in all patients (n =
69). There was no significant difference in the plasma
ECP levels of patients with and without wheezing,
(18.5 ± 16.1 ngmL vs 12.6 ± 8.8 ngmL). Meanwhile,
ECP concentrations in the nasal fluid were signifi-
cantly higher in patients with wheezing andor bron-
chial rales than in patients without them (Fig. 1, 1733
± 660 ngmL vs 680 ± 450 ngmL, p = 0.018).
ECP LEVELS IN PLASMA AND NASAL FLUID IN
RELATION TO RSV INFECTION
There was no significant difference in plasma ECP
levels between RSV-infected and other pathogen-
infected patients. Meanwhile, ECP concentrations in
the nasal fluid of RSV-infected patients were signifi-
cantly higher than those of other pathogen-infected
patients (Fig. 2, mean data was 1406 ngmL vs 630
ngmL, p = 0.04). The thirty-three of patients (80% of
total RSV-infected patients, n = 41) had distinct
wheezy breath, twenty-two (54%) had predisposition
of allergy.
ECP LEVELS IN PLASMA AND NASAL FLUID IN
RELATION TO ALLERGIC PREDISPOSITION
For both nasal fluid and blood plasma, there was no
significant difference in ECP concentrations in pa-
tients with and without a predisposition to allergy
(Fig. 3).
LINEAR REGRESSION ANALYSIS
For ECP concentrations in the nasal fluid, linear re-
Nasal Fluid ECP Levels and RSV Infection
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Fig.　1　ECP concentrations in nasal lavage and plasma in patients with or without wheez-
ing. Nasal lavage ECP concentrations (log; ng/mL) were signifi cantly elevated in patients 
with wheezing. Closed circle represents the mean value.
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Fig.　2　ECP concentrations in nasal lavage and plasma in patients with or without RSV infection. 
Nasal lavage ECP concentrations (log; ng/mL) were signifi cantly increased in patients with RSV 
infection. Closed circle represents the mean value.
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gression analysis was performed to compare the
strength of correlation with respect to wheezy bron-
chitis, RSV infection and peripheral blood leukocyte
numbers. Statistical evidence suggested the possibil-
ity of a significant correlation between nasal fluid
ECP concentrations and both neutrophil counts and
eosinophil counts in peripheral blood (Table 2).
TIME-COURSE CHANGE IN ECP LEVELS IN
PLASMA AND NASAL FLUID
In some patients, we collected samples twice, once on
admission (infectious phase, day 0) and again at the
time when respiratory symptoms diminished (recov-
ery phase, one day before discharge; mean, 4.7 days).
For both nasal fluid and blood plasma, there was no
significant change in ECP concentrations during their
hospitalization (Fig. 4).
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Fig.　3　ECP concentrations in nasal lavage and plasma in patients with and without allergic pre-
disposition. No signifi cant difference in either nasal lavage ECP or plasma ECP was found be-
tween patients with and without allergic predisposition. Closed circle represents the mean value.
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Table　2　Monovariate and multivariated analysis to nasal ECP
Infectious phase Recovery phase
Monovariate (R) Multivariate (S) Monovariate (R) Multivariate (S)
Allergy factor (+) 0.187 0.268*
Wheeze (+) 0.130 0.227
RSV infection (+) 0.099 -0.129
Neutrophil (/μl) 0.264* 0.669** 0.570**
Eosinophil (/μl) 0.254* 0.295* 0.600** 0.446**
IgE (IU/ml) 0.035 -0.030
RSV, respiratory syncitial virus.
Value in monovariate analysis was shown as R values of correlation.
Value in multivariated analysis was shown as S values after stepwise multiple linear regression.
*p < 0.05, **p < 0.01.
DISCUSSION
RSV is a major respiratory pathogen that causes bron-
chiolitis in children less than 2 years old.12,13 The
most serious manifestations of RSV infection are
wheezing and respiratory distress, which often re-
quire hospitalization and artificial ventilation, Sigurs
et al. have demonstrated that RSV bronchiolitis in in-
fancy severe enough to cause hospitalization is a risk
factor for allergic sensitization and bronchial asthma
between age 3 and adolescence,1,14,15 but the patho-
physiology behind this development has not been
clearly characterized. Additionally, it is also well con-
firmed that mild RSV infection does not increase the
risk of frequent wheezing episodes and allergic sensi-
tization in childhood.16
In our studies, ECP concentrations in the nasal
fluid were significantly higher in hospitalized patients
with wheezing or RSV infection. There was no signifi-
cant difference in the plasma ECP levels of patients
with and without wheezing. These results show that
severe RSV and lower respiratory tract infections that
contribute to the development of wheezing initiate
the production of ECP in the airway, but do not influ-
ence plasma levels of ECP. ECP is an inflammatory
protein produced by eosinophils, however, it is not
established that only eosinophilic activation brings
the symptom of severe RSV infection and wheezy
breathing in the lower respiratory tract. Total eosino-
phil counts were not increased in all patients with
Nasal Fluid ECP Levels and RSV Infection
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Fig.　4　Changes of ECP concentrations in nasal lavage and plasma in hospitalized patients. 
ECP concentrations in nasal lavage and plasma did not change with recovery regardless of RSV 
infection. Vertical bars show mean ± SD. ■ With RSV infection (N = 10). ◆ Without RSV infec-
tion (N = 6).
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RSV infection; the eosinophil counts may not be per-
fectly proportional to the ECP levels in nasopharyn-
geal secretions from RSV-infected children as de-
scribed in a previous report.9 Some researchers have
speculated that ECP originates from neutrophils as
well as eosinophils, because neutrophils contain
mRNA transcripts for ECP.17 Another study suggests
that neutrophils might be the stimulators of eosino-
phils to produce ECP.11 In addition, our data suggest
a significant correlation between nasal fluid ECP con-
centrations and peripheral blood leukocyte counts,
not only of eosinophils also of neutrophils.
Bronchoalveolar lavage (BAL) fluid studies have
indicated that in infants with RSV bronchiolitis, neu-
trophils are the dominant inflammatory cells, ac-
counting for 50 to 76% of all cells in the lower air-
ways.5-7 During RSV infection, the inflammatory me-
diators (IL-8, TNF-α and granulocyte-macrophage
colony-stimulating factor; GM-CSF) are present in the
airways and probably originate from epithelial
cells.4-6,18 IL-8 and GM-CSF will cause an influx of
neutrophils, which in turn can further contribute to
airway inflammation by the release of their own
chemokines and granular enzymes. Neutrophil
elastase in the epithelial lining of the airways has
been reported to strongly induce inflammation and
destroy structures of the extracellular matrix in con-
junction with RSV infections.7,19,20 These findings
strongly suggest that neutrophil-mediated inflamma-
tion also plays some role in the pathophysiology of
RSV bronchiolitis.
Based on our results and previous relative findings,
we proposed that measurement of ECP in nasal fluid
may be useful to assessment of both eosinophilic and
neutrophilic inflammation in the airway of young chil-
dren. Infantile cases with severe airway inflammation
induced by neutrophils and eosinophils, and espe-
cially those with RSV infection, may develop in-
creased allergic sensitization and bronchial obstruc-
tive disease in future following airway damage. How-
ever, further longitudinal observations and quantita-
tive studies are necessary in order to confirm this
possibility.
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